Historical information contained historical information contained herein, the matters The forward-looking statements in this press release in accordance with the ‘safe harbor’provisions of the Private Securities Litigation Reform Act of 1995 http://p2sildenafil.com/disclaimer . These statements are subject to risks and uncertainties that actual results to differ materially, including regulatory review and approval of our products, the conduct, timing and results of clinical trials, including the MERLIN TIMI – 36 study, product marketing, market acceptance of products, product labeling, and other risks identified from time to time in 31st CV Therapeutics ‘ SEC reports, including the including the Annual Report on Form 10-K for the year ended December 2006. CV Therapeutics disclaims any intent or obligation to update these forward-looking statements.
Skin cancer researchers from QUT’s Institute of Health and Biomedical Innovation UV dosimeter connected to the head, back of the hands and ankles of 22 cyclists who seven-day seven-day charity cycle ride in Queensland.
AD Society comment of new research at the International Conference Alzheimer Disease is presented.